(2S,4R)-1-((2S,3S)-2-(1-fluorocyclopropanecarboxamido)-3-hydroxybutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide

ID: ALA4228692

PubChem CID: 145967743

Max Phase: Preclinical

Molecular Formula: C24H29FN4O5S

Molecular Weight: 504.58

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)[C@@H](C)O)cc1

Standard InChI:  InChI=1S/C24H29FN4O5S/c1-13-20(35-12-27-13)16-5-3-15(4-6-16)10-26-21(32)18-9-17(31)11-29(18)22(33)19(14(2)30)28-23(34)24(25)7-8-24/h3-6,12,14,17-19,30-31H,7-11H2,1-2H3,(H,26,32)(H,28,34)/t14-,17-,18+,19+/m1/s1

Standard InChI Key:  KPVWXDKGVYUNBF-OAOYMFHYSA-N

Molfile:  

     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
    8.4237  -11.7007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0192  -10.9949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6102  -11.6981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6628   -9.7726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1560  -10.5940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2386  -13.2949    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   15.7967  -13.5302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7354   -9.7731    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.8354  -14.5578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4456   -9.3606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8010   -8.8514    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.4656   -9.6010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4456  -11.0024    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.8781  -10.3114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1538   -9.7731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2360  -13.0306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3533  -15.2232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6194  -12.7241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9080  -13.7727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6563  -14.5544    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.8664  -11.8233    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.8664   -9.3647    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.7354  -10.5940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5767  -10.5940    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.8392  -12.4792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4998  -11.7269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8924  -12.2765    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.4079  -13.8313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4548  -12.7778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3101  -10.5938    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.3260  -10.9245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1883  -14.0841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5782  -13.7818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8664  -11.0024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2810  -11.9756    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  1  3  1  0
  5 34  1  1
 12  4  1  0
  7 18  1  0
 31 26  1  1
 13 23  1  0
  2 30  1  0
 15 10  1  0
 12 11  1  6
 23  2  1  0
  9 17  1  0
 20 19  2  0
  9 20  1  0
  6 33  1  0
  5 13  1  0
 18 25  2  0
 33  9  2  0
 31 14  1  0
 34 24  1  0
  7 33  1  0
 15 22  1  1
  4 24  1  0
 24 31  1  0
 29 16  1  0
 25 16  1  0
 26 27  2  0
 23  8  2  0
 35 29  1  0
 28 32  1  0
 16 28  2  0
 19  6  1  0
 14 12  1  0
  5 15  1  0
 26 35  1  0
 34 21  2  0
 32  7  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4228692

    ---

Associated Targets(Human)

VHL Tchem Von Hippel-Lindau disease tumor suppressor/Elongin B/Elongin C (158 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 504.58Molecular Weight (Monoisotopic): 504.1843AlogP: 1.06#Rotatable Bonds: 8
Polar Surface Area: 131.86Molecular Species: NEUTRALHBA: 7HBD: 4
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.87CX Basic pKa: 2.65CX LogP: -0.46CX LogD: -0.46
Aromatic Rings: 2Heavy Atoms: 35QED Weighted: 0.43Np Likeness Score: -0.55

References

1. Soares P, Gadd MS, Frost J, Galdeano C, Ellis L, Epemolu O, Rocha S, Read KD, Ciulli A..  (2018)  Group-Based Optimization of Potent and Cell-Active Inhibitors of the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase: Structure-Activity Relationships Leading to the Chemical Probe (2S,4R)-1-((S)-2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (VH298).,  61  (2): [PMID:28853884] [10.1021/acs.jmedchem.7b00675]

Source